- Home
- TFSL vs RNA Comparison
TFSL vs RNA Comparison
Compare TFSL & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFSL
- RNA
- Stock Information
- Founded
- TFSL 1938
- RNA 2012
- Country
- TFSL United States
- RNA United States
- Employees
- TFSL N/A
- RNA N/A
- Industry
- TFSL Savings Institutions
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- TFSL Finance
- RNA Health Care
- Exchange
- TFSL Nasdaq
- RNA Nasdaq
- Market Cap
- TFSL 3.9B
- RNA 4.0B
- IPO Year
- TFSL 2007
- RNA 2020
- Fundamental
- Price
- TFSL $13.30
- RNA $40.25
- Analyst Decision
- TFSL Hold
- RNA Strong Buy
- Analyst Count
- TFSL 1
- RNA 16
- Target Price
- TFSL $15.00
- RNA $69.81
- AVG Volume (30 Days)
- TFSL 406.9K
- RNA 3.7M
- Earning Date
- TFSL 10-29-2025
- RNA 11-06-2025
- Dividend Yield
- TFSL 8.55%
- RNA N/A
- EPS Growth
- TFSL 3.58
- RNA N/A
- EPS
- TFSL 0.29
- RNA N/A
- Revenue
- TFSL $308,625,000.00
- RNA $10,729,000.00
- Revenue This Year
- TFSL $6.24
- RNA N/A
- Revenue Next Year
- TFSL $8.69
- RNA $109.60
- P/E Ratio
- TFSL $45.55
- RNA N/A
- Revenue Growth
- TFSL 1.03
- RNA 1.23
- 52 Week Low
- TFSL $11.29
- RNA $21.51
- 52 Week High
- TFSL $15.00
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- TFSL 46.56
- RNA 42.09
- Support Level
- TFSL $13.05
- RNA $39.83
- Resistance Level
- TFSL $13.48
- RNA $42.42
- Average True Range (ATR)
- TFSL 0.24
- RNA 2.81
- MACD
- TFSL -0.08
- RNA -1.22
- Stochastic Oscillator
- TFSL 18.85
- RNA 28.98
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.